Nafithromycin

Description: Nafithromycin (WCK 4873) serves as an orally administered antibiotic effective against community-acquired pneumonia organisms such as Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Methicillin-susceptible Staphylococcus aureus. It displays a minimum inhibitory concentration (MIC 90) of 0.12 mg/liter against both macrolide-resistant and telithromycin-insensitive Streptococcus pneumoniae. Target: Antibiotic. Smiles: C[C@@]12[C@]([C@H](\C(=N\O[C@@H](C)C=3SC(=NN3)C4=CC=CC=N4)\N)C(=O)O1)([C@@H](C)C(=O)[C@H](C)C[C@](OC)(C)[C@H](O[C@H]5[C@H](O)[C@@H](N(C)C)C[C@@H](C)O5)[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@@H]2CC)[H]